Skip to main content

Zevra Therapeutics, Inc 10-Q for FY2026 Q2

Zevra Therapeutics, Inc. (ZVRA)

10-Q 2026-08-05 For: 2026-06-30
View Original
Added on August 05, 2026

About this 10-Q

Zevra Therapeutics, Inc filed this 10-Q on August 5, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).

Headline figures

Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$39.66M
up 53.3% from $25.88M a year earlier
Net income
$8.75M
down 88.3% from net income of $74.71M a year earlier
Diluted EPS
$0.14
down 88.4% from $1.21 a year earlier